Prime India Healthcare to introduce electronic health cards in India
The card, which is designed to store the history of diseases of the cardholder and family and previous medical records in electronic format, will help doctors to provide
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) in combination with Padcev (enfortumab vedotin) for adult patients with muscle-invasive bladder cancer (MIBC) who cannot receive or have refused cisplatin-based chemotherapy.